Incyte develops and sells prescription medicines, mainly for blood cancers and other conditions. It last closed at $114.63 on Nov 20, down 1.07% on the day. The next earnings report for INCY is expected around Tue, Feb 9, 2027. For the quarter ended Sep 2026, INCY reported EPS of -$3.86 on revenue of $1.56B, with revenue up 14.0% from a year ago. Over its last 8 reports the stock moved an average of 5.1% the session after earnings. Over the last 12 months INCY insiders bought $0 of stock on the open market and sold $67.8M, according to SEC Form 4 filings.
AI Auto Pilots
Is INCY in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold INCY.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on INCYStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
INCY · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 4% below its 20 day and 3% below its 50 day average. It is 5% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 42). The nearest support is the swing low (Jul 23) at $114.50, and the nearest resistance the Pivot at $115.47.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 3.2%/day
Key levels
$132.6052 week high+15.7%
$120.04100 day average+4.7%
$118.8420 day average+3.7%
$118.4950 day average+3.4%
$117.17Swing high (Oct 22)+2.2%
$116.66Pivot R1+1.8%
$115.47Pivot+0.7%
$114.62Last close
$114.50Swing low (Jul 23)−0.1%
$113.43Pivot S1−1.0%
$109.31200 day average−4.6%
$89.2552 week low−22.1%
Indicators
RSI (14)
41.69
Middle of its range
Neutral
MACD
-0.04
Below its signal line
Bearish
Stochastic
14.8
Near the bottom of its range
Oversold
ADX (14)
11.1
No clear trend
Williams %R
-96.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-105.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−4.2%
Change over 10 sessions
Bearish
ATR (14)
$3.64
Typical daily range, 3.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 7.0%/day
Key levels
$132.6052 week high+15.7%
$120.04100 day average+4.7%
$118.8420 day average+3.7%
$118.4950 day average+3.4%
$117.17Swing high (Oct 22)+2.2%
$116.66Pivot R1+1.8%
$115.47Pivot+0.7%
$114.62Last close
$114.50Swing low (Jul 23)−0.1%
$113.43Pivot S1−1.0%
$109.31200 day average−4.6%
$89.2552 week low−22.1%
Indicators
RSI (14)
49.82
Middle of its range
Neutral
MACD
2.95
Below its signal line
Bearish
Stochastic
46.2
Middle of its range
Neutral
ADX (14)
28.8
Trending up
Williams %R
-70.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
-49.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−5.6%
Change over 10 sessions
Bearish
ATR (14)
$7.97
Typical daily range, 7.0% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for INCY
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how INCY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow INCY usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for INCYHow many large options trades hit INCY, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in INCY in the last 90 days.
From SEC Form 4 filings by INCY's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Oct 29, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether INCY is in one of them and how their past INCY trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Incyte
Incyte is a biopharmaceutical company based in Wilmington, Delaware. It discovers, develops and sells prescription medicines, mainly for blood cancers and other conditions, including a topical cream. Physicians prescribe its products to patients, and insurers and other payors decide on coverage. Some of its products are also developed and sold with partners, including Novartis and Lilly.